Nucleic Acid Aptamers as antibody alternatives
Dr David Bunka, Chief Technical Officer, Aptamer Group
23rd April 2018
12pm – 2pm (Talk is followed by lunch and a chance to network with the Aptamer Group and other attendees to discuss your projects)
Clinical School Lecture Theatre 2, School of Clinical Medicine, Addenbrooke's Hospital
Using antibodies In research? Learn about using aptamers as an alternative for targeting proteins, small molecules and tissues
This seminar by Dr David Bunka of the ‘Aptamer Group’ will cover -
An introduction to aptamer technology and several applications through which aptamers can be used. Aptamers can be generated to target proteins, small molecules, cells and tissues, thus supporting a range of research platforms including ELISA assays, imaging, flow cytometry, biosensors, biomarkers discovery, patient stratification, and drug delivery. The talk will also explore use of this technology in identifying and validating novel targets and drug molecules, and areas in which the ‘Aptamer Group’ company is interested in building research & collaborations.
Register for the event: https://nucleic-acid-aptamers-as-antibody-alternatives.eventbrite.co.uk
Industry Technology Seminar & Networking hosted by -
Cambridge Academy of Therapeutic Sciences (CATS)
www.ats.cam.ac.uk, cats@admin.cam.ac.uk
